Literature reviews, generated by AI
Ask a question. Get a review grounded in recent research.
PubMed research · Cited sources
Ask a question. Get a review grounded in recent research.
PubMed research · Cited sources
6 free credits, then one-time credit packs from $5.
Recent research has transformed solitary fibrous tumor (SFT) from a primarily morphology-defined lesion into a molecularly characterized fibroblastic neoplasm. The recurrent NAB2–STAT6 fusion, aberrant STAT6 signaling, and nuclear STAT6 immunohistochemistry now provide central tools for diagnosis across diverse anatomic sites. Prognostic assessment combines clinicopathologic features with emerging molecular information, although late recurrence, metastasis, and marked biologic heterogeneity limit prediction. Complete surgical excision remains the foundation for localized disease, with selective radiotherapy and prolonged surveillance. For advanced SFT, antiangiogenic therapies have shown greater activity than conventional chemotherapy, while cytotoxic, immune-based, and molecularly directed strategies remain under investigation. The field is moving toward fusion-based diagnosis, individualized metastatic-risk prediction, and angiogenesis-directed systemic treatment.
Question: new solitary fibrous tumor research
Read the full reviewSpirometry may provide prognostic information in selected patients with heart failure, particularly through forced expiratory volume in one second (FEV₁), forced vital capacity (FVC), and classification of obstructive or restrictive ventilatory patterns. Lower FEV₁ and FVC, airflow obstruction, and restrictive patterns have been associated with adverse outcomes in chronic heart failure, HFpEF, and selected HFrEF populations. However, these associations are heterogeneous and may depend on heart-failure phenotype, pulmonary hypertension, and clinical context. Evidence from stable heart failure suggests prognostic value beyond recognized pulmonary disease, whereas studies of advanced heart failure, LVAD evaluation, and some exercise-physiology cohorts have found limited or absent independent associations with mortality or other outcomes. Reduced FEV₁ may have particular relevance among transplant candidates, although evidence is based on a small, selected population. Overall, spirometry is best regarded as an adjunct to clinical, imaging, hemodynamic, biomarker, and exercise-based assessment rather than as a standalone prognostic tool.
Question: Is spirometry useful for risk stratification in patients with heart failure?
Read the full reviewThe available evidence does not establish forced vital capacity (FVC) as an independent prognostic factor for hospital readmission in patients with heart failure. The directly relevant studies either did not identify FVC as an independent predictor or evaluated other pulmonary measures, populations, or outcomes. In smokers hospitalized for heart failure, computed tomography-defined emphysema, rather than FVC or other spirometric measurements, was independently associated with heart-failure readmission (PMID: 30059544). Among patients undergoing left ventricular assist device implantation, reduced diffusing capacity for carbon monoxide independently predicted cardiac readmission, whereas FVC was not evaluated as the prognostic variable (PMID: 33470633). Small-airway dysfunction, assessed by maximum mid-expiratory flow, was associated with a composite of mortality or heart-failure readmission, particularly in patients with left ventricular ejection fraction below 40%, but FVC itself was not an independent predictor (PMID: 40293436). Overall, the evidence remains insufficient to conclude that FVC independently predicts hospital readmission in heart failure.
Author: aldo lopez
Email: rockmnlr@gmail.com
Question: Is forced vital capacity an independent prognostic factor for hospital readmission in patients with heart failure?
Avascular necrosis (AVN), or osteonecrosis, is ischemic and/or cytotoxic death of bone tissue caused by impaired blood supply. Although multiple bones may be affected, the femoral head is the most common site and may undergo progressive necrosis, subchondral fracture, collapse, secondary osteoarthritis, pain, and functional loss. Major associations include corticosteroid exposure, excessive alcohol use, trauma, hematologic and coagulation disorders, metabolic and systemic disease, transplantation-related therapies, and multifocal osteonecrosis. Clinical presentation may be subtle, and plain radiographs can remain normal during early disease. Magnetic resonance imaging (MRI) is therefore central to early detection and staging. Management is determined by stage, lesion size and location, symptoms, age, and functional demands. Early disease may be approached with risk-factor modification, conservative or medical measures, and selected joint-preserving procedures, particularly core decompression. Cell-based augmentation may offer additional benefit, but evidence remains incomplete. After femoral-head collapse or advanced degenerative change, total hip arthroplasty is generally the most reliable treatment.
Question: Avascular necrosis
Read the full reviewEnoxaparin is frequently selected instead of apixaban for thromboprophylaxis because of its long clinical history, broad evidence base, established guideline support, and practical suitability for hospitalized and perioperative patients. This preference does not establish universal superiority. Apixaban has demonstrated efficacy after total hip or knee arthroplasty and may be advantageous when oral administration is reliable. However, its evidence remains more indication-specific, and concerns regarding gastrointestinal absorption, drug interactions, renal function, urgent procedures, and selected bleeding risks limit generalization across populations. Enoxaparin is particularly useful when oral therapy is unsuitable or perioperative management requires a familiar injectable agent. The choice should therefore be individualized according to indication, renal function, bleeding risk, oral intake and absorption, procedural plans, drug interactions, cost, and local protocols.
Author: aldo lopez
Email: rockmnlr@gmail.com
Question: Why for thromboprofilaxys we use enoxaparin and not apixaban?
Tea tree oil (TTO; Melaleuca alternifolia) and niaouli essential oil (NEO; commonly obtained from Melaleuca quinquenervia or M. viridiflora) are related botanical ingredients considered for antimicrobial and dermatological formulations. The supplied evidence does not include a direct, standardized head-to-head comparison; therefore, relative intrinsic efficacy cannot be established. TTO has the larger and more clinically developed evidence base, particularly for acne-oriented and antimicrobial applications. NEO evidence is more limited but supports activity against acne-associated bacteria in a nanoemulsion and composition-dependent enhancement of transdermal estradiol permeation. For both oils, chemical composition, chemotype, concentration, oxidation state, vehicle, and finished-product characteristics influence activity and tolerability. TTO is currently the more evidence-supported option for general antimicrobial skincare, whereas NEO may be especially valuable in nanoemulsion and permeation-enhancing systems.
Question: Tea tree oil vs niaouli efficacy and activity in cosmetics
Read the full reviewCarvedilol has been evaluated in several cirrhosis-related settings, but the supplied material describes distinct studies that should not be conflated. In patients with new-onset uncomplicated ascites, the CARVE-AS trial associated carvedilol with fewer ascites-related complications, acute kidney injury, refractory ascites, spontaneous bacterial peritonitis, and large-volume paracentesis, together with greater ascites resolution and reduced hepatic venous pressure gradient (PMID: 40689908). A separate randomized CARVE-AS/CALIBRE trial compared carvedilol with variceal band ligation (VBL) for primary prevention of variceal bleeding, but premature termination left it underpowered to establish comparative efficacy (PMID: 40241373). Another planned CARVE-AS trial will compare carvedilol plus endoscopic variceal ligation (EVL) with propranolol plus EVL for secondary prevention after variceal bleeding (PMID: 40288803). Indirect evidence suggests greater portal-pressure reduction with carvedilol than with propranolol, while observational data support a possible reduction in long-term decompensation compared with propranolol (PMID: 27147389; PMID: 41453085). Overall, carvedilol appears promising, but definitive conclusions remain limited by small or prematurely terminated trials, observational designs, and low-certainty comparative evidence.
Question: Summary of carve -AS trial
Read the full reviewIncretin-based therapies are increasingly evaluated for metabolic dysfunction–associated steatotic liver disease (MASLD) and metabolic dysfunction–associated steatohepatitis (MASH) in people with obesity, overweight, and/or type 2 diabetes. Across randomized trials, semaglutide, tirzepatide, and GLP-1/glucagon co-agonists consistently reduce body weight, hepatic fat, liver enzymes, and cardiometabolic risk markers. Semaglutide improved the FAST score, MRI-measured liver fat, weight, liver enzymes, glycated hemoglobin, and low-density lipoprotein cholesterol in a 52-week randomized trial of patients with suspected at-risk MASH. Tirzepatide produced greater reductions in MRI-proton density fat fraction than insulin degludec, while pemvidutide, cotadutide, and efinopegdutide demonstrated substantial improvements in hepatic steatosis and biochemical markers. Biopsy-based evidence indicates that semaglutide and tirzepatide can promote MASH resolution without worsening fibrosis, although consistent regression of established fibrosis has not been established. Current evidence is therefore strongest for improvements in steatosis and steatohepatitis activity, whereas antifibrotic and long-term clinical benefits remain uncertain.
Question: https://www.nature.com/articles/s41591-025-03783-8
Read the full reviewLas contracciones ventriculares prematuras (CVP o PVC) son activaciones eléctricas originadas en un foco ectópico del miocardio ventricular o del sistema de Purkinje. Sus mecanismos incluyen automatismo anormal, actividad desencadenada y reentrada (PMID: 37689374). Aunque pueden aparecer de forma idiopática en personas sin cardiopatía demostrable, también se asocian con enfermedad estructural o isquémica, inflamación y fibrosis miocárdica, alteraciones genéticas y del sistema de conducción, trastornos metabólicos, hipoxia, sustancias, medicamentos y activación simpática. La carga elevada y persistente puede contribuir a una miocardiopatía inducida por CVP. La relevancia clínica depende de la frecuencia, los síntomas, la relación con el ejercicio y la presencia de enfermedad cardíaca subyacente.
Question: CUÁLES SONLAS CAUSAS QUE GENERAN CONTRACCIONES VENTRICULARES PREMATURAS?
Read the full reviewThe Circle of Willis is an arterial anastomotic ring at the brain’s base that connects the anterior and posterior cerebral circulations. Through its communicating vessels, it offers a potential route for collateral blood flow when a major feeding artery is narrowed or occluded, although this protection depends on the completeness, symmetry, and caliber of its component vessels. Anatomical variation is common, with reported frequencies differing according to population, developmental stage, imaging method, and definitions of completeness. Studies have documented diverse configurations, frequent posterior communicating artery hypoplasia or aplasia, and lower completeness of the posterior than anterior portion. Embryonic development, vessel dimensions, and the balance between carotid and vertebrobasilar flow contribute to this variability. These features are relevant to cerebral ischemia, cerebrovascular disease, neurovascular imaging, and neurosurgical or endovascular planning.
Question: circle of willis
Read the full review